Clinical Trials Directory

Trials / Recruiting

RecruitingNCT05561088

Efficacy and Safety of Head Acupuncture After Mechanical Thrombectomy for Acute Ischemic Stroke

A Single-center, Prospective, Randomized, Controlled Study of Mechanical Thrombectomy Followed by Acupuncture for Acute Ischemic Stroke

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
272 (estimated)
Sponsor
Xi'an No.3 Hospital · Other Government
Sex
All
Age
18 Years – 100 Years
Healthy volunteers
Not accepted

Summary

To evaluate the efficacy and safety of head acupuncture combined with endovascular therapy for cerebral infarction compared with endovascular therapy alone

Detailed description

Control group: Mechanical thrombectomy followed by the guideline recommended treatment for acute ischemic stroke; Experimental group: After mechanical thrombectomy, head acupuncture and the treatment regimen recommended by the guideline for acute ischemic stroke were administered

Conditions

Interventions

TypeNameDescription
OTHERScalp Acupuncturemplementation plan of head needle: The middle frontal line (MS1), the middle parietal line (MS5) and the back parietal and temporal oblique line (MS7) in the International Standardization Program for the Name of the first needle Point in 1989 were selected, and the needles were inserted along the shape of each section. One needle was inserted into the middle frontal line and the middle parietal line, and two needles were inserted into the back parietal and temporal oblique line. The KWD-808I pulse electrotherapy instrument produced by Changzhou Wujin Great Wall Medical Equipment Co., Ltd. is used on the needle handle after lifting, inserting and twisting. The continuous waveform was used, the voltage was 2-4 V, the frequency was 60-80 times /min, the intensity was tolerated by the patient, the needle was kept for 30min, and the treatment was performed once a day.
OTHERThe treatment recommended in the guidelines for acute ischemic stroke was administeredThe treatment recommended in the guidelines for acute ischemic stroke was administered

Timeline

Start date
2023-04-27
Primary completion
2026-02-28
Completion
2028-10-31
First posted
2022-09-30
Last updated
2023-05-12

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT05561088. Inclusion in this directory is not an endorsement.